---
input_text: 'Restricted diffusion in Canavan disease. INTRODUCTION: Canavan disease
  is a megalencephalic leukodystrophy due to deficiency of the enzyme aspartoacylase.
  Proton MR spectroscopy finding of elevated N-acetyl-L: -aspartate is considered
  diagnostic of Canavan disease. CASE REPORT: We report a case of Canavan disease,
  which showed restricted diffusion in diffusion-weighted imaging and discuss the
  cause of it.'
raw_completion_output: |-
  primary_disease: Canavan disease
  medical_actions: Proton MR spectroscopy
  symptoms: restricted diffusion in diffusion-weighted imaging
  chemicals: N-acetyl-L:-aspartate
  action_annotation_relationships: Proton MR spectroscopy TREATS restricted diffusion IN Canavan disease; Elevated N-acetyl-L:-aspartate PREVENTS diagnosis IN Canavan disease
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Elevated N-acetyl-L:-aspartate PREVENTS diagnosis IN Canavan disease

  ===

extracted_object:
  primary_disease: MONDO:0010079
  medical_actions:
    - Proton MR spectroscopy
  symptoms:
    - restricted diffusion in diffusion-weighted imaging
  chemicals:
    - N-acetyl-L:-aspartate
  action_annotation_relationships:
    - subject: Proton MR spectroscopy
      predicate: TREATS
      object: restricted diffusion
      qualifier: MONDO:0010079
      subject_extension: Proton MR spectroscopy
    - subject: Elevated N-acetyl-L:-aspartate
      predicate: PREVENTS
      object: diagnosis
      qualifier: MONDO:0010079
      subject_extension: N-acetyl-L:-aspartate
named_entities:
  - id: CHEBI:26708
    label: NA
  - id: MONDO:0010100
    label: Tay-Sachs disease
  - id: MONDO:0008876
    label: Bloom syndrome
  - id: MONDO:0010079
    label: Canavan disease
  - id: HP:0001304
    label: torsion dystonia
  - id: MONDO:0009653
    label: mucolipidosis type IV
  - id: MONDO:0019391
    label: Fanconi anemia
  - id: MONDO:0018150
    label: Gaucher disease
  - id: HP:0001929
    label: factor XI deficiency
  - id: MONDO:0009287
    label: glycogen storage disease type 1a
  - id: MONDO:0009563
    label: maple syrup urine disease
  - id: MONDO:0018088
    label: familial Mediterranean fever
  - id: MONDO:0009291
    label: glycogen storage disease type III
  - id: MONDO:0009131
    label: Familial dysautonomia
  - id: MONDO:0044843
    label: torsion dystonia
  - id: CHEBI:21547
    label: N-acetylaspartate (NAA)
  - id: CHEBI:15351
    label: Acetyl coenzyme A
  - id: CHEBI:30089
    label: Acetate
  - id: HP:0001250
    label: seizures
  - id: HP:0001138
    label: Optic neuropathy
  - id: MAXO:0009004
    label: Whole exome sequencing (WES)
  - id: MAXO:0000536
    label: Prenatal diagnosis by chorionic villi sampling (CVS)
  - id: HP:0002329
    label: Drowsiness
  - id: HP:0001252
    label: Hypotonia
  - id: HP:0000741
    label: Apathy
  - id: HP:0012447
    label: Abnormal myelination
  - id: MAXO:0000530
    label: Carrier screening
  - id: MONDO:0009061
    label: cystic fibrosis
  - id: MONDO:0009756
    label: Niemann-Pick disease type A
  - id: HP:0001263
    label: developmental delay
  - id: HP:0000256
    label: macrocephaly
  - id: MAXO:0001001
    label: Gene therapy
  - id: MONDO:0005071
    label: Neurological diseases
  - id: CHEBI:15765
    label: L-dopa
  - id: CHEBI:18243
    label: Dopamine
  - id: CHEBI:16865
    label: GABA
  - id: MONDO:0018177
    label: Glioblastoma (GBM)
  - id: CHEBI:9661
    label: Triacetin (glyceryl triacetate, GTA)
  - id: CHEBI:32954
    label: Sodium acetate
